{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T15:10:12Z","timestamp":1652800212642},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40199-021-00420-w","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T06:02:45Z","timestamp":1637733765000},"page":"153-157","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report"],"prefix":"10.1007","volume":"30","author":[{"given":"Jiuqin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"420_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2021.7683","volume":"326","author":"AK Singal","year":"2021","unstructured":"Singal AK, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA. 2021;326:165\u201376.","journal-title":"JAMA"},{"key":"420_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","volume":"15","author":"M Bernardi","year":"2018","unstructured":"Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2018;15:753\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"420_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3350\/cmh.2013.19.4.349","volume":"19","author":"TY Kim","year":"2013","unstructured":"Kim TY, Kim DJ. Acute-on-chronic liver failure. Clin Mol Hepatol. 2013;19:349\u201359.","journal-title":"Clin Mol Hepatol"},{"key":"420_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1053\/j.gastro.2016.12.026","volume":"152","author":"SL Flamm","year":"2017","unstructured":"Flamm SL, Yang YX, Singh S, et al. American Gastroenterological Association Institute guidelines for the diagnosis and management of acute liver failure. Gastroenterology. 2017;152:644\u20137.","journal-title":"Gastroenterology"},{"key":"420_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jhep.2018.05.001","volume":"69","author":"AK Singal","year":"2018","unstructured":"Singal AK, Louvet A, Shah VH, Kamath PS. Grand rounds: alcoholic hepatitis. J Hepatol. 2018;69:534\u201343.","journal-title":"J Hepatol"},{"key":"420_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u201390.","journal-title":"Hepatol Int"},{"key":"420_CR7","doi-asserted-by":"crossref","unstructured":"Tufoni M, Baldassarre M, Zaccherini G, et al. Hemodynamic and systemic effects of albumin in patients with advanced liver disease. Curr Hepatol Rep. 2020:1\u201312.","DOI":"10.1007\/s11901-020-00521-1"},{"key":"420_CR8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","volume":"69","author":"M Bernardi","year":"2020","unstructured":"Bernardi M, Angeli P, Claria J, et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020;69:1127\u201338.","journal-title":"Gut"},{"key":"420_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255\u201360.","journal-title":"Gut"},{"key":"420_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"WC Maddrey","year":"1978","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193\u20139.","journal-title":"Gastroenterology"},{"key":"420_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1080\/17474124.2019.1688143","volume":"13","author":"F Chen","year":"2019","unstructured":"Chen F, Shi Y, Liu X, et al. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure. Expert Rev Gastroenterol Hepatol. 2019;13:1129\u201335.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"420_CR12","doi-asserted-by":"crossref","unstructured":"Zhe-Bin W, Ke W, Mo ZS, et al. Early, short-term, low-dose glucocorticoid therapy effectively blocks progression of severe acute exacerbation of chronic hepatitis B to liver failure. Clin Res Hepatol Gastroenterol. 2020;101505.","DOI":"10.1016\/j.clinre.2020.07.010"},{"key":"420_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/j.gastro.2015.06.020","volume":"149","author":"PS Kamath","year":"2015","unstructured":"Kamath PS, Therneau T, Shah VH. MELDing the Lille score to more accurately predict mortality in alcoholic hepatitis. Gastroenterology. 2015;149:281\u20133.","journal-title":"Gastroenterology"},{"key":"420_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.21607","volume":"45","author":"A Louvet","year":"2007","unstructured":"Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348\u201354.","journal-title":"Hepatology"},{"key":"420_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J, et al. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113:175\u201394.","journal-title":"Am J Gastroenterol"},{"key":"420_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306\u201333.","journal-title":"Hepatology"},{"key":"420_CR17","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3389\/fimmu.2019.02490","volume":"10","author":"R Xue","year":"2019","unstructured":"Xue R, Meng Q. The management of glucocorticoid therapy in liver failure. Front Immunol. 2019;10:2490.","journal-title":"Front Immunol"},{"key":"420_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1631\/jzus.B2000249","volume":"21","author":"JW Deng","year":"2020","unstructured":"Deng JW, Yang Q, Cai XP, et al. Early use of dexamethasone increases Nr4a1 in Kupffer cells ameliorating acute liver failure in mice in a glucocorticoid receptor-dependent manner. J Zhejiang Univ Sci B. 2020;21:727\u201339.","journal-title":"J Zhejiang Univ Sci B"},{"key":"420_CR19","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391:2417\u201329.","journal-title":"Lancet"},{"key":"420_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","volume":"157","author":"J Fernandez","year":"2019","unstructured":"Fernandez J, Claria J, Amoros A, et al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology. 2019;157:149\u201362.","journal-title":"Gastroenterology"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-021-00420-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-021-00420-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-021-00420-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:56:14Z","timestamp":1652799374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-021-00420-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1007\/s40199-021-00420-w","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the Ethics Committee of Shengjing Hospital of China Medical University. This study was conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants signed a document of informed consent to Participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants signed a document of informed consent to Publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflicts of interest to declare.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}